Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5
Frequently Asked Questions
What is Market Cap of Gyre Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gyre Therapeutics Inc market cap is $711.17M.
What is the 52-week high for Gyre Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gyre Therapeutics Inc 52 week high is $19.00 as of September 14, 2025.
What is the 52-week low for Gyre Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gyre Therapeutics Inc 52 week low is $6.11 as of September 14, 2025.
What is Gyre Therapeutics Inc stock price today?
Gyre Therapeutics Inc stock price today is $7.83.
What was Gyre Therapeutics Inc stock price yesterday?
Gyre Therapeutics Inc stock price yesterday was $8.12.
What is the PE ratio of Gyre Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gyre Therapeutics Inc’s P/E ratio is 480.37.
What is the Price-to-Book ratio of Gyre Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gyre Therapeutics Inc P/B ratio is 7.7276.
What is the 50-day moving average of Gyre Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gyre Therapeutics Inc 50-day moving average is $7.62.
How many employess does Gyre Therapeutics Inc has?